Balogun Harold Advises AAIC on its Lead Investment in DrugStoc’s US $4.4 Million Series A Round

Balogun Harold advised the Africa Healthcare Master Fund (AAIC) on its lead investment in the US $4.4 million Series A funding round of DrugStoc, a Nigerian health-technology company dedicated to improving access to quality medicines across Africa.

Balogun Harold provided comprehensive legal support throughout the transaction, including due diligence, and documentation support, ensuring compliance with both Nigerian and international standards.

The venture financing supports DrugStoc’s expansion of its pharmaceutical distribution network and its mission to strengthen Africa’s healthcare supply chain.

* In line with our Deal Announcement Policy, Balogun Harold will only announce completed deals when the client has approved public disclosure or where the information is already publicly available.